(Q38006059)

26 August 2017

title

An update on treatment of onychomycosis (English)

1 reference

26 August 2017

Chander Grover

1

1 reference

26 August 2017

Ananta Khurana

series ordinal

2

1 reference

26 August 2017

publication date

30 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

55

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

541-551

1 reference

Stigmatisation in onychomycosis patients: a population-based study.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Onychomycosis: a compendium of facts and a clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

NailQoL: a quality-of-life instrument for onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Treatment options--development of consensus guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Onychomycosis in clinical practice: factors contributing to recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Onychomycosis: diagnosis and definition of cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Dermatophytoma: Recalcitrance to treatment because of existence of fungal biofilm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Genetic predisposition--understanding underlying mechanisms of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Nail morphology studies as assessments for onychomycosis treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Ultrasound-mediated nail drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Toenail onychomycosis: current and future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Review of antifungal therapy and the severity index for assessing onychomycosis: part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

The use of topical therapies to treat onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Tioconazole nail solution--an open study of its efficacy in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Trans-ungual iontophoretic delivery of terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Terbinafine: mode of action and properties of the squalene epoxidase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Terbinafine: a review of its use in onychomycosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Taste loss to terbinafine: a case-control study of potential risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Treatment of Candida nail infection with terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Terbinafine in onychomycosis with involvement by non-dermatophytic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

A review of current research in light-based technologies for treatment of podiatric infectious disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Photodynamic therapy in the treatment of superficial mycoses: an evidence-based evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Chemical avulsion with urea nail lacquer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Onychomycosis in children: treatment with bifonazole-urea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Surgical treatment of mycotic toenails

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Testing of antifungal combinations against yeasts and dermatophytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

The past, present and future of antimycotic combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Topical treatment of onychomycosis using bifonazole 1% urea/40% paste

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Treatment of nondermatophyte mold and Candida onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Resistance to azolic compounds in clinical Trichophyton spp. strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

Preclinical data and mode of action of amorolfine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2012.02199.X

10.1111/J.1439-0507.2012.02199.X

21 January 2018

Identifiers

DOI

1 reference

release_brfmxbanvfethi2xt4i37wlzky

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/brfmxbanvfethi2xt4i37wlzky

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference